These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 10583477)

  • 1. Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour.
    Ferré S; Rimondini R; Popoli P; Reggio R; Pèzzola A; Hansson AC; Andersson A; Fuxe K
    Eur J Neurosci; 1999 Nov; 11(11):3884-92. PubMed ID: 10583477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat.
    Bronstein DM; Ye H; Pennypacker KR; Hudson PM; Hong JS
    Brain Res Mol Brain Res; 1994 May; 23(3):191-203. PubMed ID: 7914658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression.
    Le Moine C; Svenningsson P; Fredholm BB; Bloch B
    J Neurosci; 1997 Oct; 17(20):8038-48. PubMed ID: 9315922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain.
    Alonso R; Gnanadicom H; Fréchin N; Fournier M; Le Fur G; Soubrié P
    Eur J Neurosci; 1999 Mar; 11(3):967-74. PubMed ID: 10103090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1-Receptor-related priming is attenuated by antisense-meditated 'knockdown' of fosB expression.
    Crocker SJ; Morelli M; Wigle N; Nakabeppu Y; Robertson GS
    Brain Res Mol Brain Res; 1998 Jan; 53(1-2):69-77. PubMed ID: 9473593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA; Gerfen CR
    Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ; Yu J; Marshall JF
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of c-fos and zif/268 gene expression in rat striatal neurons, following stimulation of D1-like dopamine receptors, involves protein kinase A and protein kinase C.
    Simpson CS; Morris BJ
    Neuroscience; 1995 Sep; 68(1):97-106. PubMed ID: 7477939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons.
    Gerfen CR; Keefe KA; Gauda EB
    J Neurosci; 1995 Dec; 15(12):8167-76. PubMed ID: 8613751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors.
    Keefe KA; Gerfen CR
    J Comp Neurol; 1996 Apr; 367(2):165-76. PubMed ID: 8708002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens.
    Yamada H; Kuroki T; Nakahara T; Hashimoto K; Tsutsumi T; Hirano M; Maeda H
    Brain Res; 2007 Feb; 1131(1):88-96. PubMed ID: 17169339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration.
    Svenningsson P; Nomikos GG; Fredholm BB
    J Neurosci; 1995 Nov; 15(11):7612-24. PubMed ID: 7472512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML; Graybiel AM; David JC; Robertson HA
    J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Fink JS
    Brain Res; 1996 Dec; 743(1-2):124-30. PubMed ID: 9017239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat.
    Gresch PJ; Walker PD
    Brain Res Mol Brain Res; 1999 Jun; 70(1):125-34. PubMed ID: 10381550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in CArG-binding protein A expression levels following injection(s) of the D1-dopamine agonist SKF-82958 in the intact and 6-hydroxydopamine-lesioned rat.
    Rushlow WJ; Rajakumar B; Flumerfelt BA; Naus CC; Rajakumar N
    Neuroscience; 2000; 98(1):69-78. PubMed ID: 10858613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.